Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-18

Clinical Trial Update: Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation [Phase 4]

View source ↗

Summary

Completed Phase 4 trial evaluating growth hormone treatment in children diagnosed with intrauterine growth restriction, including cases described as foetal grow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norditropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Foetal Growth Problem, Small for Gestational Age | Phase 4 | Status: COMPLETED